Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

Click on the organs and learn more about cancer types

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

Name	Type	Specific against	Item no.	Amount	Price
GSK-LSD1 dihydrochloride	Inhibitors	Other	A21815-5 Adooq	5 mg	Login Compare	GSK-LSD1 dihydrochloride
GSK-LSD1 dihydrochloride	Inhibitors	Other	A21815-10 Adooq	10 mg	Login Compare	GSK-LSD1 dihydrochloride
GSK-LSD1 dihydrochloride	Inhibitors	Other	A21815-50 Adooq	50 mg	Login Compare	GSK-LSD1 dihydrochloride
GSK-LSD1 dihydrochloride	Inhibitors	Other	A21815-100 Adooq	100 mg	Login Compare	GSK-LSD1 dihydrochloride
ADU-S100 ammonium salt	Inhibitors	Other	A21781-25 Adooq	25 mg	Login Compare	ADU-S100 ammonium salt
GSK-LSD1 dihydrochloride	Inhibitors	Other	A21815-1 Adooq	1 mg	Login Compare	GSK-LSD1 dihydrochloride
GSK-LSD1 dihydrochloride	Inhibitors	Other	A21815-2 Adooq	2 mg	Login Compare	GSK-LSD1 dihydrochloride
GSK-LSD1 dihydrochloride	Inhibitors	Other	A21815-25 Adooq	25 mg	Login Compare	GSK-LSD1 dihydrochloride
GSK-LSD1 dihydrochloride	Inhibitors	Other	A21815-500 Adooq	500 mg	Login Compare	GSK-LSD1 dihydrochloride
GSK-LSD1 dihydrochloride	Inhibitors	Other	A21815-10mM-D Adooq	10 mM x 1 mL in DMSO	Login Compare	GSK-LSD1 dihydrochloride
B-Raf inhibitor 1 dihydrochloride	Inhibitors	Other	A21834-2 Adooq	2 mg	Login Compare	B-Raf inhibitor 1 dihydrochloride
B-Raf inhibitor 1 dihydrochloride	Inhibitors	Other	A21834-25 Adooq	25 mg	Login Compare	B-Raf inhibitor 1 dihydrochloride
B-Raf inhibitor 1 dihydrochloride	Inhibitors	Other	A21834-50 Adooq	50 mg	Login Compare	B-Raf inhibitor 1 dihydrochloride
B-Raf inhibitor 1 dihydrochloride	Inhibitors	Other	A21834-100 Adooq	100 mg	Login Compare	B-Raf inhibitor 1 dihydrochloride
B-Raf inhibitor 1 dihydrochloride	Inhibitors	Other	A21834-500 Adooq	500 mg	Login Compare	B-Raf inhibitor 1 dihydrochloride
B-Raf inhibitor 1 dihydrochloride	Inhibitors	Other	A21834-10mM-D Adooq	10 mM x 1 mL in DMSO	Login Compare	B-Raf inhibitor 1 dihydrochloride
Moclobemide	Inhibitors	Other	A11885-10 Adooq	10 mg	Login Compare	Moclobemide
Moclobemide	Inhibitors	Other	A11885-25 Adooq	25 mg	Login Compare	Moclobemide
Moclobemide	Inhibitors	Other	A11885-50 Adooq	50 mg	Login Compare	Moclobemide
Moclobemide	Inhibitors	Other	A11885-100 Adooq	100 mg	Login Compare	Moclobemide
Chlortetracycline Hydrochloride	Inhibitors	Other	A11927-1000 Adooq	1000 mg	Login Compare	Chlortetracycline Hydrochloride
Rolitetracycline	Inhibitors	Other	A13851-100 Adooq	100 mg	Login Compare	Rolitetracycline
Rolitetracycline	Inhibitors	Other	A13851-500 Adooq	500 mg	Login Compare	Rolitetracycline
Marizomib (NPI-0052, salinosporamide A)	Inhibitors	Other	A13853-1 Adooq	1 mg	Login Compare	Marizomib (NPI-0052, salinosporamide A)
Marizomib (NPI-0052, salinosporamide A)	Inhibitors	Other	A13853-2 Adooq	2 mg	Login Compare	Marizomib (NPI-0052, salinosporamide A)

Name Price

GSK-LSD1 dihydrochloride

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21815-5
Amount	5 mg
Available

GSK-LSD1 dihydrochloride

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21815-10
Amount	10 mg
Available

GSK-LSD1 dihydrochloride

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21815-50
Amount	50 mg
Available

GSK-LSD1 dihydrochloride

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21815-100
Amount	100 mg
Available

ADU-S100 ammonium salt

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21781-25
Amount	25 mg
Available

GSK-LSD1 dihydrochloride

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21815-1
Amount	1 mg
Available

GSK-LSD1 dihydrochloride

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21815-2
Amount	2 mg
Available

GSK-LSD1 dihydrochloride

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21815-25
Amount	25 mg
Available

GSK-LSD1 dihydrochloride

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21815-500
Amount	500 mg
Available

GSK-LSD1 dihydrochloride

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21815-10mM-D
Amount	10 mM x 1 mL in DMSO
Available